Stay updated on Atrasentan in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible changes to the study details or layout are observed.
    Difference
    0.0%
    Check dated 2026-02-14T04:55:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision 3.4.1 replaces 3.4.0, indicating a minor maintenance update with no substantive changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T05:36:43.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Added: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-24T01:30:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    - Revision updated from v3.3.3 to v3.3.4 in the page header. This is a metadata change and does not modify the study details, eligibility criteria, or locations.
    Difference
    0.0%
    Check dated 2026-01-17T01:18:52.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The study Locations list was updated to add new sites across the U.S., Argentina, Australia, Italy, China, India, Spain, and other regions, and several previously listed locations were removed.
    Difference
    2%
    Check dated 2025-12-19T07:22:19.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page, with no changes to the study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-27T22:53:04.000Z thumbnail image

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.